Abstract

Author Correction: Enhanced NF-\u03baB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis

Highlights

  • Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts nonresponse to adalimumab in psoriasis

  • The original version of the Source Data file associated with this Article included an error in the ‘Fig. 6 and Supp Fig. 15 tab’, in which CD274 was inadvertently represented by a number series ranging from CD274 to CD300

  • The HTML has been updated to include a corrected version of Source Data; the original incorrect version of Source Data can be found as Supplementary Information associated with this Correction

Read more

Summary

Introduction

The original version of the Source Data file associated with this Article included an error in the ‘Fig. 6 and Supp Fig. 15 tab’, in which CD274 was inadvertently represented by a number series ranging from CD274 to CD300. Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts nonresponse to adalimumab in psoriasis

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.